Matches in Wikidata for { <http://www.wikidata.org/entity/Q61447575> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q61447575 description "article published in Tumori" @default.
- Q61447575 description "wetenschappelijk artikel" @default.
- Q61447575 description "wissenschaftlicher Artikel" @default.
- Q61447575 description "наукова стаття" @default.
- Q61447575 name "When should trastuzumab be stopped after achieving complete response in HER2-positive metastatic breast cancer patients?" @default.
- Q61447575 name "When should trastuzumab be stopped after achieving complete response in HER2-positive metastatic breast cancer patients?" @default.
- Q61447575 type Item @default.
- Q61447575 label "When should trastuzumab be stopped after achieving complete response in HER2-positive metastatic breast cancer patients?" @default.
- Q61447575 label "When should trastuzumab be stopped after achieving complete response in HER2-positive metastatic breast cancer patients?" @default.
- Q61447575 prefLabel "When should trastuzumab be stopped after achieving complete response in HER2-positive metastatic breast cancer patients?" @default.
- Q61447575 prefLabel "When should trastuzumab be stopped after achieving complete response in HER2-positive metastatic breast cancer patients?" @default.
- Q61447575 P1433 Q61447575-6EC25587-9C5F-498C-A6D3-7872D0F17B2F @default.
- Q61447575 P1476 Q61447575-760B4118-EA0D-4AEE-8A07-94E3F600FB25 @default.
- Q61447575 P2093 Q61447575-74370C69-86B2-4D4A-AEEB-DE622A16454B @default.
- Q61447575 P2093 Q61447575-AE822B1B-D5A9-406F-BFCA-6DE25D665283 @default.
- Q61447575 P2093 Q61447575-B2D8A58A-9E55-49D1-9DF9-D64574FFBB49 @default.
- Q61447575 P304 Q61447575-CA1CD6D8-5EAA-4580-8979-DE5310D9BC64 @default.
- Q61447575 P31 Q61447575-0D95BE9E-021B-4D9C-A731-E1F3E7F13CC2 @default.
- Q61447575 P407 Q61447575-64890491-AA57-4C2B-B35D-12C04DA77864 @default.
- Q61447575 P433 Q61447575-F8569888-567C-4885-BC64-74C8D720FEFA @default.
- Q61447575 P478 Q61447575-E9D820B6-49D2-4E41-B01A-E91BB11852F5 @default.
- Q61447575 P50 Q61447575-D28F6A51-0FD1-41E1-8A87-D5EAA59DD02D @default.
- Q61447575 P698 Q61447575-4CF766CD-9635-4E21-9CC1-751384D44067 @default.
- Q61447575 P921 Q61447575-410FE7B4-32E0-4240-802D-2B7D96903CCB @default.
- Q61447575 P921 Q61447575-E48B2D8A-5F1C-4A66-89CF-7D25FD2FA94C @default.
- Q61447575 P698 18038883 @default.
- Q61447575 P1433 Q15757838 @default.
- Q61447575 P1476 "When should trastuzumab be stopped after achieving complete response in HER2-positive metastatic breast cancer patients?" @default.
- Q61447575 P2093 "Cristina Ghiotto" @default.
- Q61447575 P2093 "Manuela Beda" @default.
- Q61447575 P2093 "Umberto Basso" @default.
- Q61447575 P304 "491-2" @default.
- Q61447575 P31 Q13442814 @default.
- Q61447575 P407 Q1860 @default.
- Q61447575 P433 "5" @default.
- Q61447575 P478 "93" @default.
- Q61447575 P50 Q56942857 @default.
- Q61447575 P698 "18038883" @default.
- Q61447575 P921 Q12859063 @default.
- Q61447575 P921 Q412616 @default.